Trial Search Results

Social Anxiety Telehealth Therapy Study

The COVID-19 pandemic has substantially increased the risk of adverse mental health outcomes; while physical distancing is required to reduce infection risk, it also increases loneliness and isolation and prevents access to traditional in-person therapy, which further contribute to risk of adverse mental health outcomes. These problems may be especially acute for individuals with social anxiety disorder (as many as 12% of Americans), however there is a limited evidence-base for telehealth options to directly address social anxiety. This project aims to adapt exposure therapy for social anxiety to a telehealth and physical distancing-compatible intervention, and test whether this effectively decreases loneliness in adults with elevated social anxiety.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Stanford Investigator(s):

Intervention(s):

  • Behavioral: Telehealth CBT

Phase:

N/A

Eligibility


Inclusion Criteria:

   - Age 18+,

   - Liebowitz Social Anxiety Scale (LSAS) total score > 50

   - Fluent spoken and written English

   - Access to the internet via a smartphone or computer with a camera

   - Ability to provide informed consent.

Exclusion Criteria:

   - History of mania or psychosis

   - Moderate or severe substance use disorder within the past year

   - Current psychiatric diagnosis of greater impairment than that arising from social
   anxiety

   - High risk for suicide (>8 on the Mini International Neuropsychiatric Interview
   suicidality section)

   - Prior exposure therapy (more than 2 sessions)

   - Current psychotropic medication use

   - Current psychotherapy other than couples counseling.

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study

All

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Tali Ball, PhD
650-723-2686
Not Recruiting